Sangamo Therapeutics
SGMO
#8725
Rank
A$0.25 B
Marketcap
A$0.75
Share price
-6.45%
Change (1 day)
-75.56%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : A$9.39 Million

According to Sangamo Therapeutics 's latest financial reports the company has A$9.39 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$36.6 M-69.91%
2023-12-31$A$0.12 B-71.93%
2022-12-31$A$0.43 B-16.28%
2021-12-31$A$0.51 B-19.96%
2020-12-31$A$0.64 B4.65%
2019-12-31$A$0.61 B18.56%
2018-12-31$A$0.52 B116.6%
2017-12-31$A$0.24 B27.38%
2016-12-31$A$0.18 B-28.47%
2015-12-31$A$0.26 B4.62%
2014-12-31$A$0.25 B85.04%
2013-12-31$A$0.13 B118.5%
2012-12-31$A$62.44 M-20.09%
2011-12-31$A$78.15 M41.99%
2010-12-31$A$55.03 M-31.12%
2009-12-31$A$79.9 M1.77%
2008-12-31$A$78.51 M-4.82%
2007-12-31$A$82.49 M33.52%
2006-12-31$A$61.78 M19.55%
2005-12-31$A$51.67 M23.52%
2004-12-31$A$41.83 M-30.37%
2003-12-31$A$60.08 M-37.6%
2002-12-31$A$96.28 M-40.33%
2001-12-31$A$0.16 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
A$32.30 B 343,580.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.35 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.48 B 153,976.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$27.41 B 291,546.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$28.70 B 305,266.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B 1,269,754.24%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$9.11 B 96,916.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$78.14 B 831,343.22%๐Ÿ‡บ๐Ÿ‡ธ USA